Ethane

Ethane

SCHEMBL108080

CC.O=COCl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chloromethane SCHEMBL1814391 0.91
SCHEMBL102156 0.91
SCHEMBL5078402 0.87
SCHEMBL27897205 0.86
SCHEMBL28559195 0.86
SCHEMBL27425167 0.86
Water SCHEMBL28057661 0.86
Methane SCHEMBL204080 0.86
SCHEMBL27528511 0.86
Propane SCHEMBL1420935 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 228 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190177281-A1 PROCESS FOR THE PREPARATION OF 5-[[[(2S)-2-AMINO-3-[4-(AMINOCARBONYL)-2,6-DIMETHYLPHENYL]-1-OXOPROPYL] [(1S)-1-(4-PHENYL-1H-IMIDAZOL-2-YL)ETHYL]AMINO] METHYL-2-METHOXYBENZOIC ACID AND ITS POLYMORPHS THEREOF MSN LABORATORIES PRIVATE LIMITED (IN) 2019-06-13 US claimed
WO-2017191650-A1 PROCESS FOR THE PREPARATION OF 5-[[[(2S)-2-AMINO-3-[4-(AMINOCARBONYL)-2,6-DIMETHYLPHENYL]-1-OXOPROPYL][(1S)-1-(4-PHENYL-1H-IMIDAZOL-2-YL)ETHYL]AMINO]METHYL-2-METHOXYBENZOIC ACID AND ITS POLYMORPHS THEREOF MSN LABORATORIES PRIVATE LIMITED (IN) 2017-11-09 WO claimed
JP-4673313-B2 2011-04-20 JP claimed
EP-1682533-A4 PROCESS FOR PREPARING 1,2,3,9-TETRAHYDRO-9-METHYL-3- [(2-METHYL-1H-IMIDAZOLE-1-YL)METHYL]-4H-CARBAZOL-4-ONE OR ITS SALT YUHAN CORP (KR) 2007-08-29 EP claimed
JP-2007508370-A 2007-04-05 JP claimed
EP-1682533-A1 PROCESS FOR PREPARING 1,2,3,9-TETRAHYDRO-9-METHYL-3- [(2-METHYL-1H-IMIDAZOLE-1-YL)METHYL]-4H-CARBAZOL-4-ONE OR ITS SALT Yuhan Corporation (KR) 2006-07-26 EP claimed
WO-2005037822-A1 PROCESS FOR PREPARING 1,2,3,9-TETRAHYDRO-9-METHYL-3-[(2-METHYL-1H-IMIDAZOLE-1-YL)METHYL]-4H-CARBAZOL-4-ONE OR ITS SALT YUHAN CORPORATION (KR) 2005-04-28 WO claimed
WO-2023067546-A1 NOVEL BICYCLIC HETEROARYL DERIVATIVES AS SOS1:KRAS PROTEINPROTEIN INTERACTION INHIBITORS SATYARX PHARMA INNOVATIONS PVT LTD (IN) 2023-04-27 WO disclosed
EP-3810721-A1 FLUORESCENT PARTICLES WITH MOLECULARLY IMPRINTED FLUORESCENT POLYMER SHELLS FOR CELL STAINING APPLICATIONS IN CYTOMETRY AND MICROSCOPY Bundesrepublik Deutschland, Vertreten durch den Bundesminister für Wirtschaft und Energie, dieser Vertreten durch den Präsidenten der (DE) 2021-04-28 EP disclosed
EP-3603674-A1 COMBINATION OF MORPHINAN COMPOUNDS AND ANTIDEPRESSANT FOR THE TREATMENT OF INTRACTABLE AND CHRONIC PAIN CONCERT PHARMACEUTICALS, INC. (US) 2020-02-05 EP disclosed
WO-2019243617-A1 FLUORESCENT PARTICLES WITH MOLECULARLY IMPRINTED FLUORESCENT POLYMER SHELLS FOR CELL STAINING APPLICATIONS IN CYTOMETRY AND MICROSCOPY BUNDESREPUBLIK DEUTSCHLAND, VERTRETEN DURCH DEN BUNDESMINISTER FÜR WIRTSCHAFT UND ENERGIE, DIESER VERTRETEN DURCH DEN PRÄSIDENTEN DER BUNDESANSTALT FÜR MATERIALFORSCHUNG UND - PRÜFUNG (BAM) (DE) 2019-12-26 WO disclosed
WO-2019193572-A1 AN IMPROVED PROCESS FOR THE PREPARATION REMOGLIFLOZIN ETABONATE OR PHARMACEUTICALLY ACCEPTABLE SALT, SOLVATE, HYDRATE THEREOF GLENMARK PHARMACEUTICALS LIMITED (IN) 2019-10-10 WO disclosed
US-20190177281-A1 PROCESS FOR THE PREPARATION OF 5-[[[(2S)-2-AMINO-3-[4-(AMINOCARBONYL)-2,6-DIMETHYLPHENYL]-1-OXOPROPYL] [(1S)-1-(4-PHENYL-1H-IMIDAZOL-2-YL)ETHYL]AMINO] METHYL-2-METHOXYBENZOIC ACID AND ITS POLYMORPHS THEREOF MSN LABORATORIES PRIVATE LIMITED (IN) 2019-06-13 US disclosed
EP-0784629-A1 PEPTIDYL COMPOUNDS AND THEIR THERAPEUTIC USE AS INHIBITORS OF METALLOPROTEASES Chiroscience Limited (GB) 1997-07-23 EP disclosed
WO-1996011209-A1 PEPTIDYL COMPOUNDS AND THEIR THERAPEUTIC USE AS INHIBITORS OF METALLOPROTEASES CHIROSCIENCE LIMITED (GB) 1996-04-18 WO disclosed
US-4971962-A ANTIBIOTICS FOR TREATMENT OF DISEASES RESISTANT TO PENICILLINS LUCKY, LTD. (KR) 1990-11-20 US disclosed
EP-0341607-A2 Anticoagulant peptide alcohols MERRELL DOW PHARMACEUTICALS INC. (US) 1989-11-15 EP disclosed
EP-0303863-A2 Benzenesulfonyl carboxamide compounds, intermediate compounds and methods of preparation thereof and use of said compounds and intermediate compounds as herbicidal agents AMERICAN CYANAMID COMPANY (US) 1989-02-22 EP disclosed
EP-0235980-A1 Textiles having stain resistance E.I. DU PONT DE NEMOURS AND COMPANY (US) 1987-09-09 EP disclosed
EP-0226346-A1 Bicyclic sulfonamide derivatives SHIONOGI & CO., LTD. (JP) 1987-06-24 EP disclosed